Health
Rheumatoid Arthritis Drug Baricitinib Linked to Reduced Mortality in COVID-19 Patients – Cath Lab Digest
November 13, 2020 — The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according…
November 13, 2020 The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition…
-
Noosa News21 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General24 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba
-
Noosa News14 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General14 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final